CD274 and neoplasm: Further studies are required to determine if blockade of PD-1 or PD-L1 could reduce tumour cell growth and induce tumour cell death via immune-independent mechanisms using in vivo pre-clinical models which will help further elucidate the biological role and clinical potential for targeting these pathways to reduce tumour growth in OAC.